ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Kansas City, KS, USA:

Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial

The goal of this clinical research study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of t...

Active, not recruiting
Pancreatic Cancer
Drug: Niraparib Treatment

Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 5 other locations

with either gemcitabine plus nab-paclitaxel (G/NP) or FOLFIRINOX in the treatment of participants with locally advanced, unresectable pancreatic...

Active, not recruiting
Pancreatic Cancer Non-resectable
Drug: Pamrevlumab + Gemcitabine + Nab-paclitaxel or Pamrevlumab + FOLFIRINOX
Drug: Placebo + Gemcitabine + Nab-paclitaxel or Placebo + FOLFIRINOX

Phase 3

FibroGen
FibroGen

Kansas City, Missouri, United States and 89 other locations

ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...

Active, not recruiting
Pancreatic Cancer
Biological: XB2001 or Placebo

Phase 1, Phase 2

XBiotech

Merriam, Kansas, United States and 27 other locations

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Kansas City, Kansas, United States and 15 other locations

Researchers want to discover if the new drug "TG01" will work with participants' bodies to help their immune system attack any cancer cells ...

Enrolling
Pancreas Cancer
Drug: QS-21
Biological: TG01 Vaccine

Phase 2

University of Kansas
University of Kansas

Kansas City, Missouri, United States and 4 other locations

This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumor...

Enrolling
Exocrine Pancreatic Cancer
Carcinoma, Non-Small-Cell Lung
Drug: cisplatin
Drug: carboplatin

Phase 2

Seagen
Seagen

Fairway, Kansas, United States and 63 other locations

This is a phase 1 first in human, dose escalation trial of GP-2250 administered in combination with gemcitabine in subjects with advanced pancreatic...

Enrolling
Pancreatic Cancer, Adult
Drug: GP-2250

Phase 1

Geistlich Pharma

Fairway, Kansas, United States and 3 other locations

The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors an...

Active, not recruiting
Esophageal Cancer
Urologic Cancer
Drug: Niraparib

Phase 2

Tempus AI
Tempus AI

Saint Joseph, Missouri, United States and 79 other locations

and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...

Active, not recruiting
Neoplasms Pancreatic
Pancreatic Adenocarcinoma
Drug: Gemcitabine - 21 day cycle
Drug: Lomustine

Phase 2

Actuate Therapeutics

Kansas City, Kansas, United States and 65 other locations

nivolumab or standard of care. It is being tested against advanced and/or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic...

Enrolling
Advanced Cancer
Gastric Cancer
Drug: Albumin-Bound Paclitaxel
Drug: Gemcitabine

Phase 1, Phase 2

Transcenta

Kansas City, Kansas, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems